Literature DB >> 27388879

Assessing the impact of nocturia on health-related quality-of-life and utility: results of an observational survey in adults.

Fredrik Andersson1,2, Peter Anderson3, Tove Holm-Larsen4, James Piercy3, Karel Everaert5, Tim Holbrook3.   

Abstract

BACKGROUND AND AIM: The impact of nocturia (getting up at night to void) on health-related quality-of-life (HRQoL) is often under-estimated. This study investigated the relative burden in terms of HRQoL and utilities of nocturia in a real-world setting.
METHODS: Patient data were collected from two surveys: a nocturia-specific, cross-sectional survey of physicians and their patients (DSP), and a general UK population health survey (HSFE). Utilities (EQ-5D-5L), productivity (Work Productivity and Activity Index), and the impact of nocturia symptoms (Nocturia Impact Diary and Overactive Bladder Questionnaires) were assessed against the number of voids. A robust linear regression model with propensity score weights was used to control for confounding factors in estimating utilities.
RESULTS: Physician-recorded data were available from 8,738 patients across the US, Germany, Spain, France, and the UK; of these, 5,335 (61%) included patient-reported outcomes. In total, 6,302 controls were drawn from the two surveys and compared to 1,104 nocturia patients. Deterioration of HRQoL was associated with increasing number of night-time voids (p < 0.0001). In particular, significant differences were observed between 0-1 and ≥2 voids (p < 0.001). The regression model demonstrated that nocturia (≥2 per night) is associated with a modest but significant deterioration in utility of 0.0134 (p < 0.05). LIMITATIONS: The cause of nocturia is multifactorial and the mostly elderly patients may have several concomitant diseases. The authors tried to adjust for the most common ones, but there may be diseases or unknown relationships not included.
CONCLUSIONS: Nocturia negatively affected HRQoL and patient utility. A clear effect is seen already at two voids per night. Every effort should, therefore, be made to reduce nocturia below the bother threshold of two voids per night.

Entities:  

Keywords:  EQ-5D; Nocturia; Nocturia Impact (NI) diary; Observational survey; Quality-of-life (QoL); Utility; WPAI

Mesh:

Year:  2016        PMID: 27388879     DOI: 10.1080/13696998.2016.1211136

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  10 in total

1.  The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study.

Authors:  Po-Ming Chow; Shih-Ping Liu; Yao-Chi Chuang; Kyu-Sung Lee; Tag Keun Yoo; Limin Liao; Jian-Ye Wang; Ming Liu; Budiwan Sumarsono; Jar Jar Jong
Journal:  World J Urol       Date:  2018-05-23       Impact factor: 4.226

2.  The impact of overactive bladder on health-related quality of life in Korea: based on the results of a Korean Community Health Survey.

Authors:  Sang-Kyu Kim; Seon-Ha Kim
Journal:  Qual Life Res       Date:  2020-11-20       Impact factor: 4.147

3.  The change of IPSS 7 (nocturia) score has the maximum influence on the change of Qol score in patients with lower urinary tract symptoms.

Authors:  Woo Suk Choi; Hwancheol Son
Journal:  World J Urol       Date:  2018-08-02       Impact factor: 4.226

4.  Patients' Lived Experiences of Nocturia: A Qualitative Study of the Evening, the Night, and the Next Day.

Authors:  Andrew Trigg; Fredrik L Andersson; Natalie V J Aldhouse; Donald L Bliwise; Helen Kitchen
Journal:  Patient       Date:  2017-12       Impact factor: 3.883

5.  Nocturia in patients with cognitive dysfunction: a systematic review of the literature.

Authors:  Rebecca Haddad; Thomas F Monaghan; Charles Joussain; Véronique Phé; Wendy Bower; Saskia Roggeman; Gilberte Robain; Karel Everaert
Journal:  BMC Geriatr       Date:  2020-07-06       Impact factor: 3.921

6.  Psychometric validation and interpretation of the Nocturia Impact Diary in a clinical trial setting.

Authors:  Stacie Hudgens; Amy Howerter; Ela Polek; Fredrik L Andersson
Journal:  Qual Life Res       Date:  2021-12-21       Impact factor: 3.440

Review 7.  Korean guideline of desmopressin for the treatment of nocturia in men.

Authors:  Eu Chang Hwang; Hyun Jin Jung; Mi Ah Han; Myung Ha Kim; Seong Hyeon Yu; Hyun Cheol Jeong; Jun Seok Kim; Sung Hyun Paick; Jeong Kyun Yeo; Jae Hung Jung
Journal:  Investig Clin Urol       Date:  2022-09

8.  Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.

Authors:  Ting Zhou; Haijing Guan; Luying Wang; Yao Zhang; Mingjun Rui; Aixia Ma
Journal:  Front Public Health       Date:  2021-06-29

Review 9.  A practical approach to the management of nocturia.

Authors:  Matthias Oelke; Stefan De Wachter; Marcus J Drake; Antonella Giannantoni; Mike Kirby; Susan Orme; Jonathan Rees; Philip van Kerrebroeck; Karel Everaert
Journal:  Int J Clin Pract       Date:  2017-10-05       Impact factor: 2.503

10.  Impact of nocturia on patients' health-related quality of life and healthcare resource utilisation compared with OAB and BPH: Results from an observational survey in European and American patients.

Authors:  Veronica Y Zeng; Gary Milligan; James Piercy; Peter Anderson; Fredrik L Andersson
Journal:  Int J Clin Pract       Date:  2019-08-27       Impact factor: 3.149

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.